Vcanbio Cell & Gene Engineering Corp Stock

Vcanbio Cell & Gene Engineering Corp Forward P/E

The Forward P/E Ratio of Vcanbio Cell & Gene Engineering Corp (600645.SS) as of Aug 4, 2026 is 116.42. In the previous year, Forward P/E Ratio was 109.75 — a change of 6.08% (higher).

Forward P/E

116.42

YoY

6.08%

Last updated:

Forward P/E Ratio of Vcanbio Cell & Gene Engineering Corp is 2026 116.42 . Forward P/E Ratio of Vcanbio Cell & Gene Engineering Corp was 2025 109.75 . It decreases by 6.08% higher compared to the previous year.
Access this data via the Eulerpool API

Vcanbio Cell & Gene Engineering Corp Stock analysis

What does Vcanbio Cell & Gene Engineering Corp do? Vcanbio Cell & Gene Engineering Corp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vcanbio Cell & Gene Engineering Corp stock

Forward P/E Ratio of Vcanbio Cell & Gene Engineering Corp is 116.42 in 2026.

Forward P/E Ratio of Vcanbio Cell & Gene Engineering Corp changed from 109.75 to 116.42, representing a 6.08% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Vcanbio Cell & Gene Engineering Corp since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Vcanbio Cell & Gene Engineering Corp with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Vcanbio Cell & Gene Engineering Corp

All Key Metrics — Vcanbio Cell & Gene Engineering Corp